These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia. Gordon SN; Doster MN; Kines RC; Keele BF; Brocca-Cofano E; Guan Y; Pegu P; Liyanage NP; Vaccari M; Cuburu N; Buck CB; Ferrari G; Montefiori D; Piatak M; Lifson JD; Xenophontos AM; Venzon D; Robert-Guroff M; Graham BS; Lowy DR; Schiller JT; Franchini G J Immunol; 2014 Dec; 193(12):6172-83. PubMed ID: 25398324 [TBL] [Abstract][Full Text] [Related]
7. Early antibody therapy can induce long-lasting immunity to SHIV. Nishimura Y; Gautam R; Chun TW; Sadjadpour R; Foulds KE; Shingai M; Klein F; Gazumyan A; Golijanin J; Donaldson M; Donau OK; Plishka RJ; Buckler-White A; Seaman MS; Lifson JD; Koup RA; Fauci AS; Nussenzweig MC; Martin MA Nature; 2017 Mar; 543(7646):559-563. PubMed ID: 28289286 [TBL] [Abstract][Full Text] [Related]
8. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge. Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095 [TBL] [Abstract][Full Text] [Related]
9. Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection. Wu Y; Xue J; Wang C; Li W; Wang L; Chen W; Prabakaran P; Kong D; Jin Y; Hu D; Wang Y; Lei C; Yu D; Tu C; Bardhi A; Sidorov I; Ma L; Goldstein H; Qin C; Lu L; Jiang S; Dimitrov DS; Ying T J Virol; 2019 Oct; 93(20):. PubMed ID: 31375583 [TBL] [Abstract][Full Text] [Related]
10. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741 [TBL] [Abstract][Full Text] [Related]
11. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251. Buge SL; Murty L; Arora K; Kalyanaraman VS; Markham PD; Richardson ES; Aldrich K; Patterson LJ; Miller CJ; Cheng SM; Robert-Guroff M J Virol; 1999 Sep; 73(9):7430-40. PubMed ID: 10438833 [TBL] [Abstract][Full Text] [Related]
12. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322 [TBL] [Abstract][Full Text] [Related]
13. Safety and Immunological Evaluation of Interleukin-21 Plus Anti-α4β7 mAb Combination Therapy in Rhesus Macaques. Pino M; Uppada SB; Pandey K; King C; Nguyen K; Shim I; Rogers K; Villinger F; Paiardini M; Byrareddy SN Front Immunol; 2020; 11():1275. PubMed ID: 32765488 [TBL] [Abstract][Full Text] [Related]
14. Early treatment of SIV+ macaques with an α Santangelo PJ; Cicala C; Byrareddy SN; Ortiz KT; Little D; Lindsay KE; Gumber S; Hong JJ; Jelicic K; Rogers KA; Zurla C; Villinger F; Ansari AA; Fauci AS; Arthos J Mucosal Immunol; 2018 May; 11(3):932-946. PubMed ID: 29346349 [TBL] [Abstract][Full Text] [Related]
18. Protection of Newborn Macaques by Plant-Derived HIV Broadly Neutralizing Antibodies: a Model for Passive Immunotherapy during Breastfeeding. Rosenberg YJ; Jiang X; Cheever T; Coulter FJ; Pandey S; Sack M; Mao L; Urban L; Lees J; Fischer M; Smedley J; Sidener H; Stanton J; Haigwood NL J Virol; 2021 Aug; 95(18):e0026821. PubMed ID: 34190597 [TBL] [Abstract][Full Text] [Related]
19. Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6. Genescà M; McChesney MB; Miller CJ J Intern Med; 2009 Jan; 265(1):67-77. PubMed ID: 19093961 [TBL] [Abstract][Full Text] [Related]
20. A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges. Gautam R; Nishimura Y; Pegu A; Nason MC; Klein F; Gazumyan A; Golijanin J; Buckler-White A; Sadjadpour R; Wang K; Mankoff Z; Schmidt SD; Lifson JD; Mascola JR; Nussenzweig MC; Martin MA Nature; 2016 May; 533(7601):105-109. PubMed ID: 27120156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]